哈萨克斯坦共和国医生对仿制药的知识和态度
Zandulla Nakipov1, Dinara Kaliyeva1, Assiya Turgambayeva1
1Department of Public Health and Management, NJSC Astana Medical University, Astana, Kazakhstan.
Medical journal of the Islamic Republic of Iran
|October 14, 2024
概括
哈萨克斯坦的医生承认仿制药 (GDs),但担心它们的有效性和安全性. 建议制定有针对性的教育计划,以提高GD的采用率并降低医疗保健成本.
科学领域:
- 药物经济学 药物经济学
- 医疗保健服务研究 医疗服务研究
- 医学教育 医学教育
背景情况:
- 仿制药 (GD) 对于降低医疗保健系统和患者的药物成本至关重要.
- 了解医生对GD的看法对于优化其利用至关重要.
研究的目的:
- 评估哈萨克斯坦医生对仿制药 (GD) 的知识和态度.
主要方法:
- 在哈萨克斯坦六个地区的450名医生进行了一项采用经过验证的19项调查问卷的横截面调查.
- 统计分析包括构造有效性的主要组件因子分析,可靠性的克朗巴赫α,以及群组比较的曼-惠特尼/克鲁斯卡尔-瓦利斯测试.
主要成果:
- 只有57.8%的医生同意GD与品牌药物具有生物等价性.
- 很大一部分人怀疑GD的有效性 (45%) 并认为副作用 (32%).
- 大多数 (71.2%) 认为品牌药物需要更高的安全标准,82.7% 要求提供更多关于 GD 安全性和有效性的信息.
结论:
- 哈萨克斯坦的医生表现出对GD的认识,但对其安全性和有效性存在持续的担忧.
- 实施针对性教育计划,重点关注GD生物等价性,安全性和有效性,对于促进它们的使用至关重要.
相关概念视频
Drug Nomenclature
1.7K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.7K
Prescription, Nonprescription and Orphan Drugs
701
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
701
Bioequivalence: Overview
932
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
932
Drug Abuse and Addiction: Pharmacological Phenomena
447
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
447
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Drug Distribution: Plasma Protein Binding
5.0K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
5.0K


